UPDATE: Oppenheimer Starts Spruce Biosciences, Inc. (SPRB) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Spruce Biosciences (SPRB) Climbs 25% Following $15 Price Target at Oppenheimer
December 17, 2021 6:18 AM ESTSpruce Biosciences (NASDAQ: SPRB) Climbs 25% Following $15 Price Target at Oppenheimer
... More